Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Fundamental & Clinical Pharmacology
|
January 1, 1990
Specificity of the phase I trial for cytotoxic drugs in oncology
J P Armand, M Klink-Alakl, G Recondo, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
A new anticancer agent (LY186641) interferes with creatinine assay
M M Bonnay, G Recondo, A J Gouyette, et al.
European Journal of Cancer & Clinical Oncology
|
November 1, 1989
96-hour continuous infusion of cis-platinum, 5-fluorouracil and bleomycin in recurrent or metastatic head and neck squamous cell carcinoma, unexpected anemia
G Recondo, M Benhamed, E Cvitkovic, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular
|
April 28, 2016
Radionecrosis versus disease progression in brain metastasis. Value of (18)F-DOPA PET/CT/MRI
J Hernández Pinzón, D Mena, M Aguilar, et al.
Southern Medical Journal
|
July 1, 1991
Perianal ulcer in disseminated histoplasmosis
G Recondo, A Sella, J Y Ro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1992
Pharmacokinetics and metabolism of 4'-iodo-4'-deoxy-doxorubicin in humans
J Robert, J P Armand, S Huet, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Phase I and pharmacology study of flavone acetic acid administered two or three times weekly without alkalinization
M de Forni, G G Chabot, J P Armand, et al.
American Journal of Clinical Oncology
|
October 1, 1990
Phase II study of cisplatin and continuous-infusion 5-fluorouracil and bleomycin for recurrent and metastatic head and neck squamous-cell carcinoma
E Tellez-Bernal, M Belehradek, G Recondo, et al.
Anticancer Research
|
May 1, 1994
5-Fluorouracil and interferon-alpha in chemotherapy refractory bladder carcinoma: an effective regimen
C J Logothetis, E Hossan, G Recondo, et al.
Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1989
Phase II study of mitozolomide (M & B 39,565) in head and neck cancer
P Herait, J P Armand, M Benahmed, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Fundamental & Clinical Pharmacology
|
January 1, 1990
Specificity of the phase I trial for cytotoxic drugs in oncology
J P Armand, M Klink-Alakl, G Recondo, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
A new anticancer agent (LY186641) interferes with creatinine assay
M M Bonnay, G Recondo, A J Gouyette, et al.
European Journal of Cancer & Clinical Oncology
|
November 1, 1989
96-hour continuous infusion of cis-platinum, 5-fluorouracil and bleomycin in recurrent or metastatic head and neck squamous cell carcinoma, unexpected anemia
G Recondo, M Benhamed, E Cvitkovic, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular
|
April 28, 2016
Radionecrosis versus disease progression in brain metastasis. Value of (18)F-DOPA PET/CT/MRI
J Hernández Pinzón, D Mena, M Aguilar, et al.
Southern Medical Journal
|
July 1, 1991
Perianal ulcer in disseminated histoplasmosis
G Recondo, A Sella, J Y Ro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1992
Pharmacokinetics and metabolism of 4'-iodo-4'-deoxy-doxorubicin in humans
J Robert, J P Armand, S Huet, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Phase I and pharmacology study of flavone acetic acid administered two or three times weekly without alkalinization
M de Forni, G G Chabot, J P Armand, et al.
American Journal of Clinical Oncology
|
October 1, 1990
Phase II study of cisplatin and continuous-infusion 5-fluorouracil and bleomycin for recurrent and metastatic head and neck squamous-cell carcinoma
E Tellez-Bernal, M Belehradek, G Recondo, et al.
Anticancer Research
|
May 1, 1994
5-Fluorouracil and interferon-alpha in chemotherapy refractory bladder carcinoma: an effective regimen
C J Logothetis, E Hossan, G Recondo, et al.
Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1989
Phase II study of mitozolomide (M & B 39,565) in head and neck cancer
P Herait, J P Armand, M Benahmed, et al.
Page
of 2